ロード中...
Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
PURPOSE: In an attempt to identify biomarkers that can reliably predict long-term outcomes to immunotherapy in metastatic melanoma, we investigated the prognostic role of [(18)F]FDG PET/CT, performed at baseline and early during the course of anti-PD-1 treatment. METHODS: Twenty-five patients with s...
保存先:
| 出版年: | Eur J Nucl Med Mol Imaging |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8113306/ https://ncbi.nlm.nih.gov/pubmed/33336264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-05137-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|